Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2008
11/18/2008CA2259430C Water miscible erythromycin solutions
11/18/2008CA2257840C Method for the control of infestations of honeybee colonies
11/18/2008CA2249361C Enhancement of microbial colonisation of the gastrointestinal tract
11/18/2008CA2247115C Inhibition of selectin binding
11/18/2008CA2210491C Antagonists of interleukin-15
11/18/2008CA2136230C Clostridium perfringens vaccines
11/18/2008CA2124329C Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
11/18/2008CA2102234C Peritoneal dialysis composition and method usable during and after peritonitis
11/13/2008WO2008137826A2 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
11/13/2008WO2008137758A2 Amino acid lipids and uses thereof
11/13/2008WO2008137717A1 Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
11/13/2008WO2008137496A1 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
11/13/2008WO2008137470A1 Multi-chain lipophilic polyamines
11/13/2008WO2008137164A1 Edible thin film strips and process for making
11/13/2008WO2008136850A2 Cobalamin conjugates useful as imaging and therapeutic agents
11/13/2008WO2008136773A1 Functionalization of nanoparticles by glucosamine derivatives
11/13/2008WO2008136759A1 Stabilized suspension
11/13/2008WO2008136636A1 Composition for fast disintegrating tablet containing herbal extract and its preparation method
11/13/2008WO2008136611A1 Natriuretic peptide conjugate using carrier substance
11/13/2008WO2008136536A1 Hybrid gel comprising chemically cross-linked hyaluronic acid derivative, and pharmaceutical composition using the same
11/13/2008WO2008136392A1 Preparation for oral administration
11/13/2008WO2008136380A1 Method for production of tablet
11/13/2008WO2008136016A1 A stable controlled release oral solid dosage form composition and a process thereof
11/13/2008WO2008135734A1 Novel antibody and use in diagnosis and therapy of arthropathies
11/13/2008WO2008135674A2 Ibuprofen, cyclodextrines and ternary agent complexes, and pharmaceutical uses thereof
11/13/2008WO2008135601A2 Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
11/13/2008WO2008135563A1 Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof
11/13/2008WO2008135562A1 Self-precipitating pharmaceutical formulations for the modified release of active principle
11/13/2008WO2008135500A1 High concentration factor vii polypeptide formulations comprising an aromatic preservative and an antioxidant
11/13/2008WO2008135361A2 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof
11/13/2008WO2008134876A1 Cancerous disease modifying antibodies
11/13/2008WO2008134819A1 Improved dosage form and process
11/13/2008WO2008134817A1 Composite carriers for dry powder inhalation therapy
11/13/2008WO2008089403A3 Oligosaccharides comprising an aminooxy group and conjugates thereof
11/13/2008WO2008083678A3 Pharmaceutically active compounds
11/13/2008WO2008064910A3 Metastasis-specific peptides and their diagnostic and therapeutic applications
11/13/2008WO2008062429A3 Particles for delivery of active ingredients, process of making and compositions thereof
11/13/2008WO2008048947A3 Apparatus for and related method of inhibiting lewis acid degradation in a vaporizer
11/13/2008WO2008017029A3 Drug carriers, their synthesis, and methods of use thereof
11/13/2008WO2007127665A3 Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
11/13/2008WO2007125089A3 Antibodies for the detection of bacillus anthracis and vaccine against b. anthracis infections
11/13/2008WO2007113885A8 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
11/13/2008WO2007109303A3 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders
11/13/2008WO2007056279A3 Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors
11/13/2008US20080281236 Devices and methodologies useful in body aesthetics
11/13/2008US20080281084 Using charged polymers to enhance solubility of polypeptide in aqueous solutions
11/13/2008US20080281079 Bioactivation Of Particles
11/13/2008US20080281000 Crosslinked gels; polysaccharides grafted with alkoxyether amides; used in hydraulic fracturing of oil wells and as dispersants in paint and dye industeries; cosmetics; drug delivery carriers
11/13/2008US20080280999 Process for Making Pharmaceutical Compositions with a Transient Plasticizer
11/13/2008US20080280998 Bifunctional Derivatives of Polyethylene Glycol, Their Preparation and Use
11/13/2008US20080280997 Cyclic acetal obtained by reacting C2 to C 4 aldhydes with polyols containing 3 to 6 carbon atoms; etherification; solubilizing active material
11/13/2008US20080280984 Transdermal Delivery of Beneficial Substances Effected By a Hostile Biophysical Environment
11/13/2008US20080280958 Administering a phosphodiesterase inhibitor; bioavailability; skin disorders; respiratory system disorders; using roflumilast
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008US20080280813 Complex drug delivery composition and method for treating cancer
11/13/2008US20080279955 Pharmaceutical microparticles
11/13/2008US20080279950 Nano-particles comprising cucurbituril derivatives, pharmaceutical composition containing the same, and process for the preparation thereof
11/13/2008US20080279949 Such as paclitaxel and stabilizer
11/13/2008US20080279945 Water soluble gel; gene expression of nucleic acid segments encoding therapy constructs including peptides, polypeptides, ribozymes and catalytic Rna to cells or tissues of animals; cardiovascular disorders; muscular dystrophy
11/13/2008US20080279940 For treatment or prevention of chronic pain
11/13/2008US20080279929 Nanoparticulate and Controlled Release Compositions Comprising Cefditoren
11/13/2008US20080279922 Immobilization with polyoxyethylene glycol; adjust circulation half-life
11/13/2008US20080279921 Gel-formulations of hydrophobic photosensitizers for mucosal applications
11/13/2008US20080279918 Composition charged with liposome; injecting into target cell; in vitro protein synthesis in gap between liposomes; drug delivery
11/13/2008US20080279916 Liposome Preparation
11/13/2008US20080279915 Matrix-Controlled Transdermal Therapeutic System Based on an Adhesive for Administering Norelgestromin or the Combination Thereof with an Estrogen
11/13/2008US20080279908 Hydroxyapatite-Binding Peptides for Bone Growth and Inhibition
11/13/2008US20080279820 Compositions and Methods for Treating Burns
11/13/2008US20080279815 Method for developing testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
11/13/2008US20080279783 Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
11/13/2008US20080279778 Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs
11/13/2008US20080279777 Compositions that include a hydrophobic compound and a polyamino acid conjugate
11/13/2008DE19830732B4 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung A composition comprising at least one lipid levels influencing drug and its use
11/13/2008DE102007022457A1 Plasmamodifizierte natürliche Minerale mit nanoskaligen Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung Plasma modified natural minerals having nanoscale features, processes for their preparation and their use
11/13/2008CA2686866A1 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
11/13/2008CA2686735A1 Amino acid lipids and uses thereof
11/13/2008CA2685873A1 Self-precipitating pharmaceutical formulations for the modified release of active principle
11/13/2008CA2684906A1 Cancerous disease modifying antibodies
11/13/2008CA2684173A1 Process for production of tablet
11/13/2008CA2684126A1 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof
11/13/2008CA2683741A1 Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof
11/13/2008CA2682250A1 Ibuprofen, cyclodextrines and ternary agent complexes, and pharmaceutical uses thereof
11/12/2008EP1990062A1 Granules, tablets and method of producing the same
11/12/2008EP1990061A2 Pharmaceutical composition for transdermal or transmucosal delivery
11/12/2008EP1990050A1 Disinfectant ointment
11/12/2008EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation
11/12/2008EP1990045A1 Polysaccharide capsules and methods of preparation
11/12/2008EP1990040A1 Nanoparticle delivery vehicle
11/12/2008EP1988925A2 Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates
11/12/2008EP1988924A2 New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition
11/12/2008EP1988911A2 Compositions and methods for transport of molecules with enhanced release properties across biological barriers
11/12/2008EP1988910A2 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
11/12/2008EP1988886A1 Delayed release pharmaceutical oral dosage form and method of making same
11/12/2008EP1988877A2 Therapeutic compositions comprising ingenol-3-angelate
11/12/2008EP1708679B1 Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin
11/12/2008EP1682582A4 Method for the mass production of immunoglobulin constant region
11/12/2008EP1639011B1 Pegylated single domain antibodies (dAb)
11/12/2008EP1608346B1 Alpha-hydroxy acid ester drug delivery compositions and methods of use
11/12/2008EP1594545B1 Pharmaceutical composition for transdermal or transmucosal administration
11/12/2008EP1587484A4 Method of treating angiogenic tissue growth
1 ... 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 ... 1712